126 related articles for article (PubMed ID: 4096478)
1. Minimal walking distance following exercise treatment in patients with arterial occlusive disease.
Rosetzsky A; Struckmann J; Mathiesen FR
Ann Chir Gynaecol; 1985; 74(6):261-4. PubMed ID: 4096478
[TBL] [Abstract][Full Text] [Related]
2. Improvement of the walking ability in intermittent claudication due to superficial femoral artery occlusion with supervised exercise and pneumatic foot and calf compression: a randomised controlled trial.
Kakkos SK; Geroulakos G; Nicolaides AN
Eur J Vasc Endovasc Surg; 2005 Aug; 30(2):164-75. PubMed ID: 15890545
[TBL] [Abstract][Full Text] [Related]
3. Supervised exercise training for intermittent claudication: lasting benefit at three years.
Ratliff DA; Puttick M; Libertiny G; Hicks RC; Earby LE; Richards T
Eur J Vasc Endovasc Surg; 2007 Sep; 34(3):322-6. PubMed ID: 17587612
[TBL] [Abstract][Full Text] [Related]
4. Success of an outpatient claudication group training program for patients with peripheral arterial occlusive disease (PAOD): the Tübingen model.
Klyscz T; Jünger M; Jünger I; Hahn M; Rassner G
Cent Eur J Public Health; 1997 Mar; 5(1):13-20. PubMed ID: 9150999
[TBL] [Abstract][Full Text] [Related]
5. Thrombin and platelet inhibition with low-dose calcium-heparin in comparison with ASA in patients with peripheral arterial occlusive disease at Leriche-Fontaine IIb class.
Allegra C; Pollari G; Carioti B; Sardina M
Int J Clin Pharmacol Ther; 1994 Dec; 32(12):646-51. PubMed ID: 7881702
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of arm-ergometry versus treadmill exercise training to improve walking distance in patients with claudication.
Treat-Jacobson D; Bronas UG; Leon AS
Vasc Med; 2009 Aug; 14(3):203-13. PubMed ID: 19651669
[TBL] [Abstract][Full Text] [Related]
7. Dobutamine effect on ankle-brachial pressure index in patients with peripheral arterial occlusive disease. New noninvasive test for evaluation of peripheral circulation?
Wysokinski WE; Spittell PC; Pellikka PA; Miller WL; Seward JB
Int Angiol; 1998 Sep; 17(3):201-7. PubMed ID: 9821035
[TBL] [Abstract][Full Text] [Related]
8. Rocker-soled shoes and walking distance in patients with calf claudication.
Richardson JK
Arch Phys Med Rehabil; 1991 Jul; 72(8):554-8. PubMed ID: 2059131
[TBL] [Abstract][Full Text] [Related]
9. Local versus systemic mechanisms underlying supervised exercise training for intermittent claudication.
Stewart AH; Smith FC; Baird RN; Lamont PM
Vasc Endovascular Surg; 2008; 42(4):314-20. PubMed ID: 18319355
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of a short-course intensive rehabilitation program in patients with moderate-to-severe intermittent claudication.
Ambrosetti M; Salerno M; Tramarin R; Pedretti RF
Ital Heart J; 2002 Aug; 3(8):467-72. PubMed ID: 12407823
[TBL] [Abstract][Full Text] [Related]
11. [Therapy of peripheral arterial occlusive disease with special reference to prostaglandins].
Creutzig A
Z Gesamte Inn Med; 1991 Mar; 46(3):59-67. PubMed ID: 1828125
[TBL] [Abstract][Full Text] [Related]
12. Results from a phase II multicenter, double-blind placebo-controlled study of Del-1 (VLTS-589) for intermittent claudication in subjects with peripheral arterial disease.
Grossman PM; Mendelsohn F; Henry TD; Hermiller JB; Litt M; Saucedo JF; Weiss RJ; Kandzari DE; Kleiman N; Anderson RD; Gottlieb D; Karlsberg R; Snell J; Rocha-Singh K
Am Heart J; 2007 May; 153(5):874-80. PubMed ID: 17452167
[TBL] [Abstract][Full Text] [Related]
13. Effect of low-density lipoprotein apheresis on patients with peripheral arterial disease. Peripheral Arterial Disease LDL Apheresis Multicenter Study (P-LAS).
Tsuchida H; Shigematsu H; Ishimaru S; Iwai T; Akaba N; Umezu S
Int Angiol; 2006 Sep; 25(3):287-92. PubMed ID: 16878078
[TBL] [Abstract][Full Text] [Related]
14. [The importance of the claudication test performed on a treadmill and its use in clinical practice].
Bergovec M; Gjurović J; Radić B; Bonić I; Vukosavić D; Mihatov S
Lijec Vjesn; 1989; 111(4-5):158-63. PubMed ID: 2770404
[TBL] [Abstract][Full Text] [Related]
15. [Vagal stimulation - a new possibility for conservative treatment of peripheral arterial occlusion disease].
Payrits T; Ernst A; Ladits E; Pokorny H; Viragos I; Längle F
Zentralbl Chir; 2011 Oct; 136(5):431-5. PubMed ID: 22009541
[TBL] [Abstract][Full Text] [Related]
16. Effect of the oral hypoglycaemic sulphonylurea glibenclamide, a blocker of ATP-sensitive potassium channels, on walking distance in patients with intermittent claudication.
Mortensen UM; Nielsen-Kudsk JE; Sondergaard HM; Jakobsen P; Jensen BS; Schmitz O; Nielsen TT
Diabet Med; 2006 Mar; 23(3):327-30. PubMed ID: 16492219
[TBL] [Abstract][Full Text] [Related]
17. [Methods and results of controlled walking training in patients with peripheral arterial occlusive disease].
Cachovan M
Z Arztl Fortbild Qualitatssich; 1999 Nov; 93(9):626-32. PubMed ID: 10666825
[TBL] [Abstract][Full Text] [Related]
18. Acute impairment of the endothelial function by maximal treadmill exercise in patients with intermittent claudication, and its improvement after supervised physical training.
Andreozzi GM; Leone A; Laudani R; Deinite G; Martini R
Int Angiol; 2007 Mar; 26(1):12-7. PubMed ID: 17353883
[TBL] [Abstract][Full Text] [Related]
19. A new device for the measurement of disease severity in patients with intermittent claudication.
Coughlin PA; Kent PJ; Turton EP; Byrne P; Berridge DC; Scott DJ; Kester RC
Eur J Vasc Endovasc Surg; 2001 Dec; 22(6):516-22. PubMed ID: 11735200
[TBL] [Abstract][Full Text] [Related]
20. Abnormal cardiovascular response to exercise in patients with peripheral arterial disease: Implications for management.
Oka RK; Altman M; Giacomini JC; Szuba A; Cooke JP
J Vasc Nurs; 2005 Dec; 23(4):130-6; quiz 137-8. PubMed ID: 16326331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
